Answer: According to Merck, the pharmaceutical company that manufactures Fosamax, osteoporosis is “a systemic disease characterized by low bone mass and microarchitectural deterioration of bone, with a consequent increase in bone fragility and susceptibility to fracture.” (2001)  The problem with this definition is that a person with high bone density may fracture, while another with […]

Continue reading about Quick Question: What Is Osteoporosis?